About Scott Lyman
Form D filings for Grid Therapeutics from 2018 to 2023 list Scott Lyman as executive officer.
Scott Lyman first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Scott Lyman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Scott Lyman works with at each company, as listed on that company's latest Form D.
Grid Therapeutics LLC · Form D, Jan 5, 2023
KS
Kevin Schulman
Director
TP
Thomas Patz
Executive officer and director
EJ
Edward Patz, Jr.
CEO and director
PP
Paolo Paoletti
Director
RP
Richard Parker
Director